Multicenter Study Protocol: Research on Evaluation and Detection of Surgical Wound Complications with AI-based Recognition. (REDSCAR-trial)
Launched by UNIVERSITAT DE LES ILLES BALEARS · Jan 7, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The REDSCAR trial is a research study that aims to explore how well a smartphone app called RedScar© can detect and monitor surgical wound infections after surgery. Surgical site infections (SSIs) are a common problem that can lead to serious health issues and increased healthcare costs. This study will compare the app's ability to identify infections with traditional in-person evaluations. The researchers hope that by using RedScar©, patients can receive better follow-up care from the comfort of their homes, making recovery easier and potentially reducing the need for hospital visits.
To participate in this study, individuals must be at least 18 years old, have had either urgent or scheduled surgery, and have access to a smartphone that can download the app. They will also need to be able to attend follow-up appointments at the surgical clinic after their surgery. Participants can expect to use the app to report their recovery and receive automated assessments about their infection risk, while also having in-person check-ups at certain times. This research is important because it could lead to a more efficient way of managing postoperative care, benefiting both patients and healthcare systems alike.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants must have signed an informed consent.
- • Participants must be over 18 years of age.
- • Participants must have undergone either urgent or scheduled surgery performed via laparotomy or laparoscopy.
- • Participants need access to a smartphone capable of downloading the app with android OS.
- • Either the participant or a close family member must be able to operate the app effectively.
- • Participants must be able to attend follow-up consultations at the surgical outpatient clinic after discharge, one week post-surgery, or earlier if the app flags a potential infection.
- Exclusion Criteria:
- • Patients who lack access to a smartphone or are unable to properly use the app.
- • Patients unfamiliar with mobile devices or unable to comprehend the app's functionality or questions.
- • Patients who did not provide informed consent.
- • Patients who are unable to comply with the follow-up requirements.
About Universitat De Les Illes Balears
The Universitat de les Illes Balears (UIB) is a leading academic institution located in Spain, dedicated to advancing knowledge through innovative research and education. With a strong emphasis on interdisciplinary collaboration, UIB promotes excellence in various fields, including health sciences. The university's commitment to clinical research is reflected in its robust infrastructure, experienced faculty, and strategic partnerships, enabling the development and implementation of clinical trials that aim to improve patient outcomes and contribute to medical advancements. UIB is dedicated to fostering a research environment that prioritizes ethical standards, scientific rigor, and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Madrid, , Spain
Menorca, , Spain
Palma, , Spain
Palma, , Spain
Mahón, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported